TCL Archive Regorafenib Trial Meets Primary Endpoint; Overall Survival Improved by 29 Percent January 27, 2012
TCL Archive Report Doesn’t Quell Concerns About Duke Genomics Research, Biostatisticians Say May 14, 2010